ReviewJournal of thrombosis and thrombolysis2000

Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study.

S R SteinhublPubMed ↗Publisher ↗

No numbers read from the abstract.